Journal of Current Glaucoma Practice

Register      Login

VOLUME 16 , ISSUE 3 ( September-December, 2022 ) > List of Articles


A Case of Refractory Open-angle Glaucoma with Failed Baerveldt Glaucoma Implant and Trabeculectomy Treated with Ab Externo XEN Gel Stent Placement

Sahar A Amoozadeh, Michael C Yang, Ken Y Lin

Keywords : Gel stent, Glaucoma, Surgery, Tube shunt, XEN

Citation Information : Amoozadeh SA, Yang MC, Lin KY. A Case of Refractory Open-angle Glaucoma with Failed Baerveldt Glaucoma Implant and Trabeculectomy Treated with Ab Externo XEN Gel Stent Placement. J Curr Glaucoma Pract 2022; 16 (3):192-194.

DOI: 10.5005/jp-journals-10078-1371

License: CC BY-NC 4.0

Published Online: 23-01-2023

Copyright Statement:  Copyright © 2022; The Author(s).


Aim: We report a case of successful intraocular pressure (IOP) management in a patient with refractory primary open-angle glaucoma (POAG) following implantation of XEN gel implant in the same hemisphere as prior failed filtering surgeries [i.e., Baerveldt glaucoma implant (BGI) and trabeculectomy bleb)]. Background: Glaucoma is a major cause of blindness worldwide and is typically associated with elevated IOP and retinal ganglion cell loss. Treatment centers around decreasing IOP with eye drops and surgical interventions. The advent of minimally invasive glaucoma surgeries (MIGS) has expanded therapeutic options for patients who have failed traditional treatments. The XEN gel implant creates a shunt between the anterior chamber and the subconjunctival or sub-tenon's space, allowing for drainage of aqueous humor without significant tissue disruption. Given that the XEN gel implant also results in bleb formation, it is generally recommended to avoid placement in the same quadrant of prior filtering surgeries. Case description: A 77-year-old man with a 15-year history of severe POAG of OU presents with persistently elevated IOP despite multiple filtering surgeries and maximal eye drop regimen. The patient had a superotemporal BGI in OU and a scarred trabeculectomy bleb superiorly in the right eye (OD). He underwent an open conjunctiva ab externo XEN gel implant placement in the OD in the same hemisphere as previous filtering surgeries. At 12 months postoperatively, the IOP range continues to be maintained within goal without complications. Conclusion: The XEN gel implant can be successfully placed in the same hemisphere as prior filtering surgeries and can achieve goal IOP without any surgical complications at 12 months postoperatively. Clinical significance: A XEN gel implant can effectively lower patients’ IOP and can be a unique surgical option in refractory cases of POAG with multiple failed filtering surgeries, even when inserted in close proximity to prior filtering surgeries.

PDF Share
  1. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 2014;121(11):2081–2090. DOI: 10.1016/j.ophtha.2014.05.013
  2. Gedde SJ, Singh K, Schiffman JC, et al. The tube versus trabeculectomy study: interpretation of results and application to clinical practice. Curr Opin Ophthalmol 2012;23(2):118–126. DOI: 10.1097/ICU.0b013e32834ff2d1
  3. Kotecha A, Feuer WJ, Barton K, et al. Quality of life in the tube versus trabeculectomy study. Am J Ophthalmol 2017;176:228–235. DOI: 10.1016/j.ajo.2017.01.019
  4. Sandhu S, Dorey MW. Case report: xen ab interno gel stent use in a refractory glaucoma patient with previous filtration surgeries. J Glaucoma 2018;27(3):e59–e60. DOI: 10.1097/IJG.0000000000000864
  5. Harris JM, Solá-Del Valle D. Effective treatment of a normal-tension glaucoma patient with bilateral ab externo XEN gel stent implantation. Am J Ophthalmol Case Rep 2020;20:100947. DOI: 10.1016/j.ajoc.2020.100947
  6. Chaudhary A, Salinas L, Guidotti J, et al. XEN gel implant: a new surgical approach in glaucoma. Expert Rev Med Devices 2018;15(1):47–59. DOI: 10.1080/17434440.2018.1419060
  7. Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab interno gelatin stent in refractory glaucoma at 12 Months. Am J Ophthalmol 2017;183:25–36. DOI: 10.1016/j.ajo.2017.07.023
  8. De Gregorio A, Pedrotti E, Russo L, et al. Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 2018;38(3):1129–1134. DOI: 10.1007/s10792-017-0571-x
  9. Galal A, Bilgic A, Eltanamly R, et al. XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol 2017:5457246. DOI: 10.1155/2017/5457246
  10. Laroche D, Ng C, Lynch G. Baerveldt attached to XEN: a new technique to manage filed XEN glaucoma surgery. J Glaucoma 2018;27(4):382–384. DOI: 10.1097/IJG.0000000000000895
  11. De Gregorio A, Pedrotti E, Stevan G, et al. XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice. Clin Ophthalmol 2018;12:773–782. DOI: 10.2147/OPTH.S146919
  12. Christakis PG, Kalenak JW, Tsai JC, et al. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology 2016;123(10):2093–2102. DOI: 10.1016/j.ophtha.2016.06.035
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.